The goal of this trial was to see whether in patients with overweight and obesity, who dont have diabetes, if their risk of cardiovascular events could be reduced by treatment with semaglutide, explained Michael Lincoff, MD, cardiologist for Cleveland Clinic
Scale bar=100 m
Regarding CV safety, large observational studies in COPD find no increased MI risk with short-acting inhaled -agonists (SABA), whereas new initiation of long-acting -agonists (LABA) has been linked to a ~ 1.5-fold increase in severe cardiovascular events within 30 days [99, 100]
The report has been named Editor's Pick of the Month for September 2013 by the Journal's Editor-in-Chief Bryon Adinoff, M.D., Distinguished Professor in Drug and Alcohol Abuse Research at the University of Texas Southwestern Medical Center
According to the MEDVi website, compounded semaglutide injections are listed at $179 first month and $299 per month for refills